Trinity Capital Commits $50M to Sage Health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy TRIN?
Trinity Capital announced the commitment of $50M in growth capital to Sage Health, a full-risk primary care and wellness provider serving Medicare-eligible seniors. The additional capital will work to support Sage's continued investment in its senior-focused care platform and geographic expansion into new medically underserved markets. Trinity's $50M debt term loan, together with the company's prior financings, brings Sage Health's total capital raised to $170M to date.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TRIN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TRIN
Wall Street analysts forecast TRIN stock price to rise
6 Analyst Rating
5 Buy
0 Hold
1 Sell
Moderate Buy
Current: 14.370
Low
13.50
Averages
16.50
High
17.50
Current: 14.370
Low
13.50
Averages
16.50
High
17.50
About TRIN
Trinity Capital Inc. is an internally managed, closed-end, non-diversified management investment company that operates as a business development company. It is a specialty lending company that provides debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its investment objective is to generate current income and capital appreciation through its investments across five vertical markets. It seeks to achieve its investment objective by making investments consisting primarily of term loans and equipment financings and working capital loans, equity and equity-related investments. Its equipment financings involve loans for general or specific use, including acquiring equipment that is secured by the equipment or other assets of the portfolio company. It targets investments in growth-stage companies that are typically private companies, including institutional investor-based companies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Trinity Capital Dividend Investment Analysis
- Dividend Investment Strategy: The report highlights that value-oriented dividend investors typically focus on companies with strong profitability and attractive valuations, with Trinity Capital Inc being one such company.
- Dividend Payment Status: Trinity Capital Inc currently pays an annualized dividend of $2.04 per share in monthly installments, reflecting its stable cash flow and profitability, which appeals to income-seeking investors.
- Importance of Dividend History: The report emphasizes that studying a company's historical dividend payments is crucial for assessing the likelihood of continued dividends, with Trinity Capital's long-term dividend history providing significant insights for investors.
- Investment Research Tool: By utilizing a proprietary DividendRank formula, the report aims to generate a list of 'interesting' stocks based on profitability and valuation, serving as a resource for investors to conduct further research.
See More
Trinity Capital Commits $50M to Sage Health for Growth
- Capital Commitment: Trinity Capital announced a $50 million growth capital investment in Sage Health, a full-risk primary care provider for Medicare-eligible seniors, enhancing its competitive position in the healthcare market.
- Market Expansion: The funding will support Sage Health's geographic expansion into new medically underserved areas, aiming to increase the reach of its senior-focused care platform to meet rising market demand.
- Total Financing: This investment brings Sage Health's total capital raised to $170 million to date, demonstrating investor confidence in its business model and market potential, thereby solidifying its position in the industry.
- Stock Price Reaction: Trinity Capital's stock fell 0.089% in premarket trading to $14.517, reflecting the market's initial reaction to the investment, which may influence its future capital management strategies.
See More
Trinity Capital Invests $50 Million in Sage Health for Senior Care Expansion
- Capital Injection: Trinity Capital announces a $50 million investment in Sage Health to support its expansion in medically underserved areas, aiming to enhance the quality of care for Medicare-eligible seniors, which is expected to significantly improve health management outcomes.
- Integrated Care Model: Sage Health's approach, where each physician manages no more than 500 patients, allows for personalized care, aiming to improve patients' quality of life and life expectancy through longer visits and intensive chronic condition management.
- Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, indicating the company's ongoing appeal and market potential in the senior healthcare sector, which is expected to drive its expansion into new markets.
- Strategic Partnership: Trinity Capital's investment not only provides financial support but also leverages its expertise in the healthcare sector through close collaboration with Sage Health, aiming to drive positive outcomes across the industry and further solidify their partnership.
See More
Trinity Capital Commits $50 Million to Sage Health for Growth Capital
- Capital Injection: Trinity Capital announces a $50 million investment in Sage Health aimed at supporting its expansion in medically underserved areas, enhancing the quality and accessibility of healthcare for elderly patients.
- Market Demand: Sage Health focuses on providing comprehensive primary care services for Medicare-eligible seniors, with physicians managing no more than 500 patients each, allowing for longer visits and intensive management of chronic conditions.
- Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, reflecting investor confidence in its innovative healthcare model and is expected to drive further development in new markets.
- Strategic Partnership: Trinity Capital's investment not only provides financial support but also fosters close collaboration with Sage Health, aiming to achieve more meaningful outcomes in the healthcare industry and enhance the overall quality of senior healthcare services.
See More
Trinity Capital Declares Consistent Dividends for Q2 2026
- Consistent Dividends: Trinity Capital has declared a monthly dividend of $0.17 per share for April, May, and June 2026, maintaining over six years of stable dividends, which reflects the company's strong cash flow and profitability.
- Dividend Payment Schedule: The payment dates for dividends in April, May, and June 2026 are set for April 30, May 29, and June 30, respectively, ensuring timely returns for shareholders and enhancing investor confidence.
- Tax Compliance Objective: The company aims to distribute dividends approximating 90% to 100% of its taxable quarterly income to qualify as a regulated investment company under the Internal Revenue Code of 1986, ensuring tax compliance.
- Portfolio Performance: Since its inception in 2008, Trinity Capital has deployed over $5.5 billion across 463 investments, showcasing its robust presence in the private credit market and ongoing growth potential.
See More
Trinity Capital Commits $35 Million to Monteris Medical for Growth
- Investment Amount: Trinity Capital announced a commitment of $35 million to Monteris Medical, reflecting confidence and support for the growth in the MedTech sector focused on minimally invasive surgical technologies.
- Technology Background: The NeuroBlate System developed by Monteris Medical is a robotically controlled laser interstitial thermal therapy platform that utilizes MRI-guided technology to remove abnormal brain tissue, aiming to provide a less invasive alternative to traditional open neurosurgery.
- Clinical Impact: The system is designed to help patients experience lower complication rates and shorter hospital stays, enhancing overall treatment experiences, which aligns with the current healthcare industry's demand for efficient and safe treatment options.
- Commercialization Support: The funding will support the commercialization of the NeuroBlate System and the expansion of clinical research programs, which is expected to enhance Monteris Medical's competitiveness and business growth in the market.
See More
Trinity Capital Dividend Investment Analysis
- Dividend Investment Strategy: The report highlights that value-oriented dividend investors typically focus on companies with strong profitability and attractive valuations, with Trinity Capital Inc being one such company.
- Dividend Payment Status: Trinity Capital Inc currently pays an annualized dividend of $2.04 per share in monthly installments, reflecting its stable cash flow and profitability, which appeals to income-seeking investors.
- Importance of Dividend History: The report emphasizes that studying a company's historical dividend payments is crucial for assessing the likelihood of continued dividends, with Trinity Capital's long-term dividend history providing significant insights for investors.
- Investment Research Tool: By utilizing a proprietary DividendRank formula, the report aims to generate a list of 'interesting' stocks based on profitability and valuation, serving as a resource for investors to conduct further research.
See More
Trinity Capital Commits $50M to Sage Health for Growth
- Capital Commitment: Trinity Capital announced a $50 million growth capital investment in Sage Health, a full-risk primary care provider for Medicare-eligible seniors, enhancing its competitive position in the healthcare market.
- Market Expansion: The funding will support Sage Health's geographic expansion into new medically underserved areas, aiming to increase the reach of its senior-focused care platform to meet rising market demand.
- Total Financing: This investment brings Sage Health's total capital raised to $170 million to date, demonstrating investor confidence in its business model and market potential, thereby solidifying its position in the industry.
- Stock Price Reaction: Trinity Capital's stock fell 0.089% in premarket trading to $14.517, reflecting the market's initial reaction to the investment, which may influence its future capital management strategies.
See More
Trinity Capital Invests $50 Million in Sage Health for Senior Care Expansion
- Capital Injection: Trinity Capital announces a $50 million investment in Sage Health to support its expansion in medically underserved areas, aiming to enhance the quality of care for Medicare-eligible seniors, which is expected to significantly improve health management outcomes.
- Integrated Care Model: Sage Health's approach, where each physician manages no more than 500 patients, allows for personalized care, aiming to improve patients' quality of life and life expectancy through longer visits and intensive chronic condition management.
- Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, indicating the company's ongoing appeal and market potential in the senior healthcare sector, which is expected to drive its expansion into new markets.
- Strategic Partnership: Trinity Capital's investment not only provides financial support but also leverages its expertise in the healthcare sector through close collaboration with Sage Health, aiming to drive positive outcomes across the industry and further solidify their partnership.
See More
Trinity Capital Commits $50 Million to Sage Health for Growth Capital
- Capital Injection: Trinity Capital announces a $50 million investment in Sage Health aimed at supporting its expansion in medically underserved areas, enhancing the quality and accessibility of healthcare for elderly patients.
- Market Demand: Sage Health focuses on providing comprehensive primary care services for Medicare-eligible seniors, with physicians managing no more than 500 patients each, allowing for longer visits and intensive management of chronic conditions.
- Total Capital Raised: This financing brings Sage Health's total capital raised to $170 million, reflecting investor confidence in its innovative healthcare model and is expected to drive further development in new markets.
- Strategic Partnership: Trinity Capital's investment not only provides financial support but also fosters close collaboration with Sage Health, aiming to achieve more meaningful outcomes in the healthcare industry and enhance the overall quality of senior healthcare services.
See More
Trinity Capital Declares Consistent Dividends for Q2 2026
- Consistent Dividends: Trinity Capital has declared a monthly dividend of $0.17 per share for April, May, and June 2026, maintaining over six years of stable dividends, which reflects the company's strong cash flow and profitability.
- Dividend Payment Schedule: The payment dates for dividends in April, May, and June 2026 are set for April 30, May 29, and June 30, respectively, ensuring timely returns for shareholders and enhancing investor confidence.
- Tax Compliance Objective: The company aims to distribute dividends approximating 90% to 100% of its taxable quarterly income to qualify as a regulated investment company under the Internal Revenue Code of 1986, ensuring tax compliance.
- Portfolio Performance: Since its inception in 2008, Trinity Capital has deployed over $5.5 billion across 463 investments, showcasing its robust presence in the private credit market and ongoing growth potential.
See More
Trinity Capital Commits $35 Million to Monteris Medical for Growth
- Investment Amount: Trinity Capital announced a commitment of $35 million to Monteris Medical, reflecting confidence and support for the growth in the MedTech sector focused on minimally invasive surgical technologies.
- Technology Background: The NeuroBlate System developed by Monteris Medical is a robotically controlled laser interstitial thermal therapy platform that utilizes MRI-guided technology to remove abnormal brain tissue, aiming to provide a less invasive alternative to traditional open neurosurgery.
- Clinical Impact: The system is designed to help patients experience lower complication rates and shorter hospital stays, enhancing overall treatment experiences, which aligns with the current healthcare industry's demand for efficient and safe treatment options.
- Commercialization Support: The funding will support the commercialization of the NeuroBlate System and the expansion of clinical research programs, which is expected to enhance Monteris Medical's competitiveness and business growth in the market.
See More
